Circulating Tumor Cells (CTC) in Lung Cancer
J
Jessica MacLean
Primary Investigator
S
Shadia Jalal, MD
Primary Investigator
Overview
The purpose of this study is to examine rare cells called circulating tumor cells that are present in a person's blood when they have lung cancer to see if there is a relationship between a person's cancer symptoms and the number and characteristics of those cells at various times before and during cancer treatment.
Description
The purpose of this study is to examine rare cells called circulating tumor cells that are present in a person's blood when they have lung cancer to see if there is a relationship between a person's cancer symptoms and the number and characteristics of those cells at various times before and during cancer treatment.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
lung cancer
-
Age: - 100 Years
-
Gender: All
Updated on
04 May 2024.
Study ID: 1512076915
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
